KIORA PHARMACEUTICALS INC

KPHMWSEC EDGAR

Pharmaceutical PreparationsCIK: 1372514

Concept	FY2024	FY2023	FY2022	FY2021	FY2020
Revenue from Contract with Customer, Excluding Assessed Tax	—	—	—	$12.1K	$2.7M
Research and Development Expense	$4.0M	$3.4M	$5.4M	$3.6M	$5.4M
Operating Expenses	$12.6M	$12.3M	$14.2M	$8.2M	$9.8M
Operating Income (Loss)	-$12.6M	-$12.3M	-$14.2M	-$8.2M	—
Interest Expense	—	$8.6K	$6.9K	$4.2K	$325.00
Nonoperating Income (Expense)	$163.3K	-$1.4M	$272.5K	$132.9K	$107.7K
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	-$12.4M	-$13.7M	-$14.0M	-$8.1M	-$7.0M

Concept	FY2024	FY2023	FY2022	FY2021	FY2020
Assets	$13.7M	$18.7M	$20.1M	$15.2M	$10.1M
Assets, Current	$4.7M	$7.7M	$9.0M	$1.7M	$4.3M
Cash and Cash Equivalents, at Carrying Value	$2.5M	$6.0M	$7.9M	$1.2M	$3.8M
Accounts Receivable, after Allowance for Credit Loss, Current	$0.00	—	—	—	—
Liabilities	$7.6M	$7.3M	$5.6M	$8.2M	$3.5M
Liabilities, Current	$1.6M	$3.3M	$1.6M	$1.8M	$1.4M
Long-term Debt, Excluding Current Maturities	—	—	—	$278.2K

Concept	FY2024	FY2023	FY2022	FY2021	FY2020
Net Cash Provided by (Used in) Operating Activities	-$9.6M	-$10.4M	-$10.7M	-$7.3M	-$8.2M
Net Cash Provided by (Used in) Investing Activities	$0.00	$6.4K	-$157.0K	-$244.4K	$0.00
Net Cash Provided by (Used in) Financing Activities	$6.0M	$8.6M	$17.6M	$5.0M	$3.9M
Payments to Acquire Property, Plant, and Equipment	$0.00	—	$63.9K	$20.1K	$0.00

Access SEC EDGAR data via REST API. Free tier available.

from sec_edgar import SecEdgar

api = SecEdgar("YOUR_KEY")
api.revenue("AAPL", limit=5)